MDSpire - MDSpire Home

MDSpire - MDSpire Home

Home About

Advertisement

What is MDSpire?

MDSpire is an innovative platform aiming to create a smarter, faster, and more connected medical community.

Learn More

Choose specialties Cardiology Dermatology Endocrinology Family Medicine Gastroenterology Hematology Internal Medicine Neurology ObGyn Oncology Ophthalmology Optometry Pediatrics Rheumatology Pulmonary Psychiatry Pathology Surgery Orthopedic Medicine Radiology Otolaryngology Infectious Disease

June 18, 2026

FDA Expands CAPVAXIVE Pediatric Use

Kathryn Wighton
June 18, 2026
2 min

Summary
Insight Report
Poll

Objective: To expand the indication for CAPVAXIVE for pediatric patients aged 2 to 17 years with chronic medical conditions that increase the risk of pneumococc

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

June 18, 2026

Bicarbonate in Cardiac Arrest: Any Benefit?

Andrea Surnit
June 18, 2026
7 min

Summary
Quiz
Clinical Scorecard

Objective: To evaluate the effect of sodium bicarbonate on sustained return of spontaneous circulation during in-hospital cardiac arrest. Approach: Key Findings

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

The Medicine Maker

June 18, 2026

Why Refrigerants Are the Next Critical Sustainability Frontier

Lu Wang
June 18, 2026
6 min

Summary
Insight Report
Quiz
Topic Commentary

Objective: To highlight the importance of transitioning to lower-GWP refrigerants in biopharma labs for sustainability and compliance with emerging regulations,

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Get expert commentary that brings together trusted external perspectives to add deeper context and insight around a clinical topic.

Explore Commentary

The Pathologist

June 18, 2026

ASCO 2026: A New Way to Track HPV Cancer

Jessica Allerton
June 18, 2026
3 min

Summary
Insight Report
Quiz

Objective: To evaluate the effectiveness of blood-based biomarkers in monitoring treatment response and detecting recurrence in HPV-associated head and neck can

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

The Pathologist

June 18, 2026

Why Real-Time Data Matters in Infection Control

Jessica Allerton
June 18, 2026
10 min

Summary
Quiz
Clinical Scorecard
Topic Commentary

Objective: To discuss the challenges and potential of using real-time data for infection prevention and control (IPC) in healthcare settings. Approach: Key Find

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Get expert commentary that brings together trusted external perspectives to add deeper context and insight around a clinical topic.

Explore Commentary

The Ophthalmologist

June 18, 2026

Improving Glaucoma Detection in Zambia

June 18, 2026
2 min

Summary
Takeaways
Quiz
Clinical Scorecard

Objective: To evaluate the effectiveness of a one-day training intervention on direct ophthalmoscopy skills among allied ophthalmic personnel (AOP) students in

A single day of focused training can enhance glaucoma examination skills among allied ophthalmic personnel in Zambia.
Zambia has a critical shortage of ophthalmologists, with only one per 556,000 people, increasing reliance on allied ophthalmic personnel.
The study showed that structured training significantly improved knowledge and skills in glaucoma detection among AOP students.
Eighty percent of participants had limited previous ophthalmoscopy experience, indicating a gap between training and clinical readiness.
Embedding competency-based ophthalmoscopy training in AOP curricula could improve glaucoma detection in low-resource settings.

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

The Ophthalmologist

June 18, 2026

Taking FLIGHT

June 18, 2026
2 min

Summary
Insight Report
Quiz

Objective: To announce the first commercial cases of the FLIGHT procedure, a new non-incisional glaucoma surgery in Europe. Approach: Key Findings: FLIGHT is a

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Frontiers In Oncology

June 18, 2026

A Case Report of follicular dendritic cell sarcoma

Lijiao Wang
Tingshu Jiang
June 18, 2026

Summary
Takeaways
Insight Report
Quiz
Clinical Scorecard

Objective: To present a case of advanced follicular dendritic cell sarcoma (FDCS) arising in the mediastinum with multiple metastases, highlighting its diagnost

Follicular dendritic cell sarcoma (FDCS) is a rare malignant neoplasm originating from follicular dendritic cells.
The case involved a 51-year-old woman with advanced FDCS presenting with cough, dyspnea, and significant weight loss.
Diagnostic imaging revealed a mediastinal mass and multiple enlarged lymph nodes, raising suspicion for malignancy.
The patient underwent a combination therapy involving gemcitabine, docetaxel, and PD-1 monoclonal antibody.
Despite treatment, the patient experienced rapid disease progression and died approximately one month after diagnosis.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Frontiers In Oncology

June 18, 2026

Multiparametric MRI-based nomogram integrating clinicopathological factors for predicting HER2 expression status in breast cancer

Yi Chen
Xiaofeng Chen
Bowen Yue
Xinwei Zhong
Hao Zhang
Xiaohong Chen
Xiangguang Chen
Zhuozhi Dai
Zhiqi Yang
June 18, 2026

Summary
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To develop and validate an mpMRI-based nomogram incorporating clinicopathological factors for predicting HER2 status in breast cancer patients. Appro

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Oncology

June 18, 2026

Comparative study of triple intravenous chemotherapy versus dual chemotherapy combined with hepatic arterial infusion in patients with liver metastases from colorectal cancer

Aimin Zhou
Lichao Wang
Chijin Xiao
Yunan Shi
June 18, 2026

Summary
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To compare the therapeutic efficacy and safety of FOLFOXIRI triplet chemotherapy with FOLFIRI combined with hepatic arterial infusion chemotherapy (H

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Medicine

June 18, 2026

External validation of the international IgA nephropathy prediction tool in a Thai cohort

Atthaphong Phongphithakchai
Attamon Thongrueang
Thatsaphan Srithongkul
Sukit Raksasuk
Fumitaka Kawakami
Aman Tedasen
Moragot Chatatikun
June 18, 2026

Summary
Takeaways
Insight Report
Quiz

Objective: To externally validate the performance of the International IgA Nephropathy Prediction Tool (IIgANPT) in a Thai cohort with biopsy-proven IgA nephrop

The study externally validated the International IgA Nephropathy Prediction Tool in a Thai cohort with biopsy-proven IgA nephropathy.
A total of 133 patients were followed for a median of 3.4 years, with 33.8% reaching the renal endpoint.
The IIgANPT showed good discrimination with C-statistics of 0.753 and 0.754 for models with and without race, respectively.
Calibration was preserved, but confidence intervals around calibration slopes were wide, indicating limited precision.
Both model versions performed similarly, suggesting the race variable's exclusion had minimal impact on prognostic performance.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Frontiers In Medicine

June 18, 2026

Analgesic effects of different patient-controlled intravenous analgesia infusion modes post cesarean section under multimodal analgesia: a retrospective cohort study

Lin Chen
Yang Wang
Shanshan Ye
Tao Xu
Ding Huang
June 18, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To compare the analgesic efficacy of patient-controlled intravenous analgesia with and without background infusion for parturients receiving multimod

The study compared patient-controlled intravenous analgesia with and without background infusion in parturients post-cesarean delivery.
No significant differences were found in analgesia demands or pain scores between the background infusion and no background infusion groups.
The background infusion group had significantly higher opioid exposure measured in intravenous morphine equivalents postoperatively.
Multimodal analgesia included liposomal bupivacaine transversus abdominis plane block, epidural hydromorphone, and oral acetaminophen.
The addition of background infusion did not enhance analgesic efficacy and may not be necessary in multimodal analgesia regimens.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Medicine

June 18, 2026

Case Report: Exchange transfusion for hemolytic anemia and acute kidney injury associated with hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin in a patient with hepatocellular carcinoma

Caili Zhang
Yajuan Yan
Xiaojian Li
Yong Dong
June 18, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To investigate the occurrence and management of severe hemolytic anemia and acute kidney injury in a patient with hepatocellular carcinoma following

Hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin is increasingly accepted for advanced hepatocellular carcinoma treatment.
Oxaliplatin is associated with severe adverse reactions, including hemolytic anemia and acute kidney injury, particularly in colorectal cancer patients.
This case report documents the first instance of oxaliplatin-related hemolytic anemia and acute kidney injury in a hepatocellular carcinoma patient.
The patient achieved complete clinical resolution through two personalized sessions of exchange transfusion and artificial liver support therapy.
The report emphasizes the importance of recognizing and managing chemotherapy-associated complications in hepatocellular carcinoma patients.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Endocrinology

June 18, 2026

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration

Aleksander Dominikowski
Zofia Rękoś
Michał Olejarz
Ewelina Szczepanek-Parulska
Remigiusz Domin
Marek RuchaŁa
June 18, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To map the main GH–IGF-1–modulating peptides used off-label (i.e., for purposes not approved by regulatory agencies), summarise pharmacokinetic/pharm

Performance-enhancing peptides (PEPs) target the GH-IGF-1 axis and are often used off-label for physique and performance enhancement.
Commonly used PEPs include GHRH analogues, GHS, GH fragments, and IGF-1 analogues, with varying levels of clinical evidence.
Adverse effects of PEPs can include endocrine disturbances, fluid retention, musculoskeletal symptoms, and injection-site reactions.
The use of PEPs is often driven by aesthetic goals and muscle dysmorphia, leading individuals to bypass clinical oversight.
Clinicians require a framework to assess symptoms and risks associated with PEP use due to the lack of regulatory approval and robust data.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Cardiovascular Medicine

June 18, 2026

Machine learning prediction of postoperative pulmonary embolism: a multicenter external validation study highlighting inflammatory response and intraoperative hemodynamics

Shunpeng He
Yuan Liu
Yilin Wu
June 18, 2026

Summary
Takeaways
Insight Report
Quiz

Objective: To develop and externally validate a machine learning-based prediction model for postoperative pulmonary embolism (PE) and explore key clinical deter

A machine learning model was developed to predict postoperative pulmonary embolism (PE) using data from 3,494 surgical patients across six hospitals.
The model identified key predictors for postoperative PE, including age, BMI, malignancy history, and intraoperative tachycardia.
XGBoost was the most effective machine learning algorithm, achieving an AUC of 0.925 in external validation, indicating strong predictive performance.
SHAP analysis revealed influential factors for PE risk, providing insights into inflammatory and hemodynamic responses during surgery.
The study emphasizes the importance of early identification of high-risk patients to improve clinical decision-making and outcomes in postoperative care.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Frontiers In Immunology

June 18, 2026

JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases

Bingrun Li
Xiaoting Song
Cunhao Shan
Junchen He
Zihan Wang
Katarina Stevanovic
Torsten Zuberbier
Zuotao Zhao
Litao Zhang
June 18, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To review the pathogenesis of JAK-STAT pathway-associated skin diseases and the efficacy of JAK inhibitors (JAKi) therapy, while providing references

The JAK-STAT signaling pathway is crucial in the pathogenesis of various inflammatory skin disorders, including atopic dermatitis and psoriasis.
Small molecule JAK inhibitors have shown significant efficacy in treating inflammatory skin diseases, with some already approved for clinical use.
Traditional classifications of inflammatory skin diseases based on T helper cell types are inadequate for guiding targeted therapies.
A proposed functional refinement framework integrates JAK-dependent cytokine modules into the existing Th immune axis for better therapeutic guidance.
Understanding the JAK-STAT pathway enhances the mechanistic insight into inflammatory skin diseases, supporting precision medicine approaches.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Medicine

June 18, 2026

Case Report: Heparin resistance as the harbinger of heparin-induced thrombocytopenia in acute pulmonary embolism

Na Yu
Fengqiang Wang
June 18, 2026

Summary
Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

Objective: To highlight the significance of unexplained heparin resistance as an early indicator of heparin-induced thrombocytopenia (HIT) in a patient with acu

Heparin-induced thrombocytopenia (HIT) can complicate heparin therapy, leading to severe thrombotic events despite therapeutic dosing.
Unexplained heparin resistance, even before thrombocytopenia, may indicate HIT and necessitates immediate diagnostic evaluation.
In a case study, a 50-year-old man with acute pulmonary embolism exhibited heparin resistance and recurrent thrombosis prior to HIT diagnosis.
Switching from heparin to non-heparin anticoagulants, like argatroban, is crucial for managing suspected HIT to prevent life-threatening complications.
Follow-up revealed significant thrombus resolution and normalized cardiac function after appropriate management of HIT.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Frontiers In Pediatrics

June 18, 2026

Association between glucolipid metabolic indicators and the risk of suspected precocious puberty in children living with obesity: a retrospective cohort study

Tingting Hao
Yifan Li
Qingmei Zhang
June 18, 2026

Takeaways
Insight Report
Quiz
Poll
Clinical Scorecard

The study investigates the link between glucolipid metabolic markers and suspected precocious puberty in obese children.
A total of 95 children were analyzed, with 27 in the suspected precocious puberty group and 68 in the non-PP group.
Higher fasting plasma glucose, insulin, triglycerides, and uric acid levels were found in the suspected precocious puberty group.
HOMA-IR, triglycerides, and uric acid were identified as independent risk factors for suspected precocious puberty.
The findings emphasize the need for early metabolic monitoring in obese children to address precocious puberty risks.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Advertisement

Advertisement

Advertisement

About
Privacy Policy

Follow Us

Author/Creator Name

[Credentials]

[Current title or role]

Affiliations: [Institution, organization]

Specialties: Oncology Hematology

View Full Profile

Contributions:

[brand name]

Content Title Goes Here and it Will Get Clamped at Two line

[author name] July 23, 2025 5 min

[brand name]

Content Title Goes Here and it Will Get Clamped at Two line

[author name] July 23, 2025 5 min

[brand name]

Content Title Goes Here and it Will Get Clamped at Two line

[author name] July 23, 2025 5 min

Show all